Oncología

Resultados: 397
Tipo Título / Nombre Autor(es) Año
JAVELIN-bladder 100: Supervivencia global y Libre de progresión en 12 y 19,5 meses con el Mejor tratamiento de soporte, al que se añade o no Avelumab, para Cáncer urotelial avanzado o metastásico, ya tratado previamente en 1ª línea con QMT basada en platino Borrega García P 2021
Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH Vaz Batista M Pérez García JM Llombart Cussac A Cortez P Ruiz Borrego M... González Santiago S Gion M 2021
Adjuvant dabrafenib plus trametinib (DT) treatment completion in patients with resected melanoma in Spain: A retrospective observational study (GEM 1901 - DESCRIBE-AD) Manzano JL, Martín Liberal J, Fernández Morales LA, Benítez G, Medina J..., Ayala de Miguel P, et al 2021
SOLTI-1907 ATREZZO: Targeting hormonal receptor negative (HR-) or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2+ metastatic breast cancer (MBC) Ciruelos EM Pernas S Perelló A López A Salvador Bofill FJ... González Santiago S Sanfeliu E 2021
PRORADIUM: Prospective analysis of the impact of germline mutations in homologous recombination (HR) genes on the response to radium-223 for metastatic castration resistant prostate cancer (mCRPC) Castro E Lozano Mejorada R Medina A Giorgi U Romero Laorden N... Borrega P Villa Guzmán JC 2021
Safety of cemiplimab for advanced cutaneous squamous cell carcinoma: The Spanish named patient programme García Castano A, Muñoz Couselo E, Soria A, Lavernia J, Sanmartin O..., Ayala de Miguel P, et al 2021
Role of serum biomarkers of bone metabolism in metastatic castration-resistance prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra223): PRORADIUM study final results Romero Laorden N, Lorente D, Lozano Mejorada R, Sánchez Soler N, Velasco G de..., Borrega P, et al 2021
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study Kahan Z, Gil-Gil M, Ruiz-Borrego M, Carrasco E, Ciruelos E ..., González-Santiago S, et al 2021
GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours Rico M, Flamarique S, Casares C, García T..., Marcos FJ, Couñago F, et al 2021
Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer (NSCLC) Montemuiño Muñiz S, Marcos Sánchez S, Calzas Rodríguez J, Losada Vila B, Llorente Herrero E..., Marcos Jiménez FJ, et al 2021